Engineering mesoporous silica nanoparticles for drug delivery: where are we after two decades?
The present review details a chronological description of the events that took place during the development of mesoporous materials, their different synthetic routes and their use as drug delivery systems. The outstanding textural properties of these materials quickly inspired their translation to t...
Uložené v:
| Vydané v: | Chemical Society reviews Ročník 51; číslo 13; s. 5365 |
|---|---|
| Hlavní autori: | , , , , |
| Médium: | Journal Article |
| Jazyk: | English |
| Vydavateľské údaje: |
England
04.07.2022
|
| Predmet: | |
| ISSN: | 1460-4744, 1460-4744 |
| On-line prístup: | Zistit podrobnosti o prístupe |
| Tagy: |
Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
|
| Abstract | The present review details a chronological description of the events that took place during the development of mesoporous materials, their different synthetic routes and their use as drug delivery systems. The outstanding textural properties of these materials quickly inspired their translation to the nanoscale dimension leading to mesoporous silica nanoparticles (MSNs). The different aspects of introducing pharmaceutical agents into the pores of these nanocarriers, together with their possible biodistribution and clearance routes, would be described here. The development of smart nanocarriers that are able to release a high local concentration of the therapeutic cargo on-demand after the application of certain stimuli would be reviewed here, together with their ability to deliver the therapeutic cargo to precise locations in the body. The huge progress in the design and development of MSNs for biomedical applications, including the potential treatment of different diseases, during the last 20 years will be collated here, together with the required work that still needs to be done to achieve the clinical translation of these materials. This review was conceived to stand out from past reports since it aims to tell the story of the development of mesoporous materials and their use as drug delivery systems by some of the story makers, who could be considered to be among the pioneers in this area. |
|---|---|
| AbstractList | The present review details a chronological description of the events that took place during the development of mesoporous materials, their different synthetic routes and their use as drug delivery systems. The outstanding textural properties of these materials quickly inspired their translation to the nanoscale dimension leading to mesoporous silica nanoparticles (MSNs). The different aspects of introducing pharmaceutical agents into the pores of these nanocarriers, together with their possible biodistribution and clearance routes, would be described here. The development of smart nanocarriers that are able to release a high local concentration of the therapeutic cargo on-demand after the application of certain stimuli would be reviewed here, together with their ability to deliver the therapeutic cargo to precise locations in the body. The huge progress in the design and development of MSNs for biomedical applications, including the potential treatment of different diseases, during the last 20 years will be collated here, together with the required work that still needs to be done to achieve the clinical translation of these materials. This review was conceived to stand out from past reports since it aims to tell the story of the development of mesoporous materials and their use as drug delivery systems by some of the story makers, who could be considered to be among the pioneers in this area. The present review details a chronological description of the events that took place during the development of mesoporous materials, their different synthetic routes and their use as drug delivery systems. The outstanding textural properties of these materials quickly inspired their translation to the nanoscale dimension leading to mesoporous silica nanoparticles (MSNs). The different aspects of introducing pharmaceutical agents into the pores of these nanocarriers, together with their possible biodistribution and clearance routes, would be described here. The development of smart nanocarriers that are able to release a high local concentration of the therapeutic cargo on-demand after the application of certain stimuli would be reviewed here, together with their ability to deliver the therapeutic cargo to precise locations in the body. The huge progress in the design and development of MSNs for biomedical applications, including the potential treatment of different diseases, during the last 20 years will be collated here, together with the required work that still needs to be done to achieve the clinical translation of these materials. This review was conceived to stand out from past reports since it aims to tell the story of the development of mesoporous materials and their use as drug delivery systems by some of the story makers, who could be considered to be among the pioneers in this area.The present review details a chronological description of the events that took place during the development of mesoporous materials, their different synthetic routes and their use as drug delivery systems. The outstanding textural properties of these materials quickly inspired their translation to the nanoscale dimension leading to mesoporous silica nanoparticles (MSNs). The different aspects of introducing pharmaceutical agents into the pores of these nanocarriers, together with their possible biodistribution and clearance routes, would be described here. The development of smart nanocarriers that are able to release a high local concentration of the therapeutic cargo on-demand after the application of certain stimuli would be reviewed here, together with their ability to deliver the therapeutic cargo to precise locations in the body. The huge progress in the design and development of MSNs for biomedical applications, including the potential treatment of different diseases, during the last 20 years will be collated here, together with the required work that still needs to be done to achieve the clinical translation of these materials. This review was conceived to stand out from past reports since it aims to tell the story of the development of mesoporous materials and their use as drug delivery systems by some of the story makers, who could be considered to be among the pioneers in this area. |
| Author | Schüth, Ferdi Lozano, Daniel Colilla, Montserrat Vallet-Regí, María Manzano, Miguel |
| Author_xml | – sequence: 1 givenname: María orcidid: 0000-0002-6104-4889 surname: Vallet-Regí fullname: Vallet-Regí, María email: vallet@ucm.es organization: Networking Research Centre on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Madrid 28029, Spain – sequence: 2 givenname: Ferdi surname: Schüth fullname: Schüth, Ferdi organization: Department of Heterogeneous Catalysis, Max-Planck-Institut für Kohlenforschung, Kaiser-Wilhelm-Platz 1, D-45470 Mülheim an der Ruhr, Germany – sequence: 3 givenname: Daniel orcidid: 0000-0001-5902-9201 surname: Lozano fullname: Lozano, Daniel email: vallet@ucm.es organization: Networking Research Centre on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Madrid 28029, Spain – sequence: 4 givenname: Montserrat orcidid: 0000-0003-1961-4160 surname: Colilla fullname: Colilla, Montserrat email: vallet@ucm.es organization: Networking Research Centre on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Madrid 28029, Spain – sequence: 5 givenname: Miguel orcidid: 0000-0001-6238-6111 surname: Manzano fullname: Manzano, Miguel email: vallet@ucm.es organization: Networking Research Centre on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Madrid 28029, Spain |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/35642539$$D View this record in MEDLINE/PubMed |
| BookMark | eNpNkE1LxDAQhoOsuO7qxR8gOXqpJmmSNl5ElvUDFrzo1ZImkzXSNjVpXfbfW3AFD8MzLzwMzLtAsy50gNAFJdeU5OrGUpMIkULVR-iUckkyXnA--7fP0SKlT0IoLSQ7QfNcSM5Erk7R-7rb-g4g-m6LW0ihDzGMCSffeKNxp7vQ6zh400DCLkRs47jFFhr_DXF_i3cfEAHraXYT3AARD7swCUZbSHdn6NjpJsH5gUv09rB-XT1lm5fH59X9JjOCFUMGTitLa-Y0qxm1jhsBlogSuJqCdaXjUkvlrJTK1KIouNLSUGYJ1yBczpbo6vduH8PXCGmoWp8MNI3uYHqnYrJgOSMlKSf18qCOdQu26qNvddxXf52wH7tgZpI |
| CitedBy_id | crossref_primary_10_1002_smtd_202300812 crossref_primary_10_1016_j_chemphys_2025_112823 crossref_primary_10_1016_j_seppur_2025_133588 crossref_primary_10_1016_j_ejps_2024_106719 crossref_primary_10_1016_j_ijpharm_2025_125722 crossref_primary_10_1016_j_molliq_2023_123632 crossref_primary_10_1039_D4NR02987A crossref_primary_10_1016_j_carbpol_2025_124226 crossref_primary_10_1002_adhm_202405274 crossref_primary_10_1016_j_jconrel_2025_114062 crossref_primary_10_1080_09276440_2025_2532916 crossref_primary_10_1016_j_indcrop_2025_120934 crossref_primary_10_1016_j_microc_2023_108901 crossref_primary_10_1016_j_apsusc_2023_157656 crossref_primary_10_1016_j_xinn_2025_100913 crossref_primary_10_1039_D2NJ02868A crossref_primary_10_1016_j_humimm_2024_111221 crossref_primary_10_1002_smll_202400353 crossref_primary_10_1016_j_ijpharm_2025_125979 crossref_primary_10_1002_adma_202400700 crossref_primary_10_1039_D4CS00500G crossref_primary_10_1002_ange_202216188 crossref_primary_10_1016_j_jmst_2024_07_028 crossref_primary_10_3390_ijms25158097 crossref_primary_10_1134_S0020168523090091 crossref_primary_10_1016_j_bioactmat_2024_05_013 crossref_primary_10_1016_j_micromeso_2023_112841 crossref_primary_10_1016_j_micromeso_2023_112840 crossref_primary_10_1002_adfm_202404822 crossref_primary_10_1016_j_mtchem_2024_102246 crossref_primary_10_1186_s40164_025_00656_1 crossref_primary_10_1039_D5DD00274E crossref_primary_10_1016_j_micromeso_2024_113096 crossref_primary_10_1016_j_actbio_2022_10_045 crossref_primary_10_1016_j_ijpharm_2022_121978 crossref_primary_10_3390_pharmaceutics15092239 crossref_primary_10_1039_D2RA07940B crossref_primary_10_1016_j_jiec_2025_01_007 crossref_primary_10_1016_j_micromeso_2025_113603 crossref_primary_10_1016_j_trac_2023_117234 crossref_primary_10_1016_j_cej_2023_144154 crossref_primary_10_1016_j_jddst_2024_105502 crossref_primary_10_3390_ijms242216489 crossref_primary_10_1002_adma_202302858 crossref_primary_10_1177_10430342251372056 crossref_primary_10_1016_j_bioactmat_2024_05_038 crossref_primary_10_1186_s12951_023_01838_x crossref_primary_10_1016_j_bioactmat_2024_05_030 crossref_primary_10_1039_D5NR00587F crossref_primary_10_1002_adma_202512433 crossref_primary_10_3390_nano15090637 crossref_primary_10_1007_s00604_023_05712_3 crossref_primary_10_1016_j_micromeso_2024_113414 crossref_primary_10_1126_sciadv_adw5133 crossref_primary_10_1002_mabi_202300362 crossref_primary_10_1002_wnan_70023 crossref_primary_10_1016_j_jddst_2025_107466 crossref_primary_10_3390_pharmaceutics14102090 crossref_primary_10_1016_j_cej_2023_147407 crossref_primary_10_1016_j_inoche_2025_115127 crossref_primary_10_1007_s11051_024_06089_x crossref_primary_10_3390_antibiotics13020173 crossref_primary_10_1038_s41427_024_00560_w crossref_primary_10_1039_D4BM00094C crossref_primary_10_1016_j_jconrel_2025_114136 crossref_primary_10_1016_j_bioactmat_2022_08_016 crossref_primary_10_1002_adma_202418894 crossref_primary_10_1007_s11144_024_02761_4 crossref_primary_10_1016_j_jconrel_2023_01_022 crossref_primary_10_1016_j_cclet_2025_111846 crossref_primary_10_1016_j_jcis_2024_07_258 crossref_primary_10_1016_j_micromeso_2023_112810 crossref_primary_10_3390_pharmaceutics15020447 crossref_primary_10_4103_tdj_tdj_34_25 crossref_primary_10_1088_1361_648X_adc6e2 crossref_primary_10_3390_su16072673 crossref_primary_10_1016_j_jddst_2025_107455 crossref_primary_10_1089_jamp_2023_ab02_abstracts crossref_primary_10_1039_D3NR00642E crossref_primary_10_1021_acsapm_5c00124 crossref_primary_10_1002_jmv_28312 crossref_primary_10_1016_j_ijpharm_2024_124555 crossref_primary_10_3390_pharmaceutics15041316 crossref_primary_10_1080_20477724_2023_2285187 crossref_primary_10_1016_j_crmicr_2024_100323 crossref_primary_10_1016_j_jconrel_2025_113984 crossref_primary_10_1016_j_cis_2024_103296 crossref_primary_10_1002_smll_202502315 crossref_primary_10_1016_j_cej_2024_151845 crossref_primary_10_1016_j_ejpb_2024_114503 crossref_primary_10_3390_nano15120914 crossref_primary_10_1007_s10971_024_06422_9 crossref_primary_10_1016_j_chemosphere_2023_140702 crossref_primary_10_1016_j_micromeso_2023_112913 crossref_primary_10_1002_cmdc_202300374 crossref_primary_10_3390_pharmaceutics15020426 crossref_primary_10_1016_j_jconrel_2024_03_013 crossref_primary_10_1007_s12668_025_02143_7 crossref_primary_10_3390_pharmaceutics15020660 crossref_primary_10_1002_adma_202415814 crossref_primary_10_1016_j_lfs_2024_122899 crossref_primary_10_1016_j_matchemphys_2024_129820 crossref_primary_10_1007_s10934_024_01735_0 crossref_primary_10_3390_pharmaceutics14122703 crossref_primary_10_1016_j_ccr_2025_217159 crossref_primary_10_34133_bmr_0251 crossref_primary_10_1002_smsc_202400112 crossref_primary_10_1016_j_jddst_2024_106083 crossref_primary_10_1007_s00204_023_03672_4 crossref_primary_10_1002_admt_202201169 crossref_primary_10_1039_D4NH00497C crossref_primary_10_1039_D5PM00137D crossref_primary_10_1038_s41467_025_62623_y crossref_primary_10_3390_pharmaceutics15020658 crossref_primary_10_1186_s12645_023_00233_3 crossref_primary_10_1002_adtp_202200303 crossref_primary_10_1002_anbr_202400005 crossref_primary_10_1039_D2NR05528G crossref_primary_10_3390_ma15175926 crossref_primary_10_1021_acsnano_5c02321 crossref_primary_10_3390_coatings14020234 crossref_primary_10_1016_j_jcis_2023_01_028 crossref_primary_10_3390_pharmaceutics14122730 crossref_primary_10_1002_adma_202504057 crossref_primary_10_1063_5_0130769 crossref_primary_10_1016_j_colsurfb_2025_114971 crossref_primary_10_1007_s11051_023_05813_3 crossref_primary_10_3390_pharmaceutics15020365 crossref_primary_10_1002_advs_202508740 crossref_primary_10_1016_j_jcis_2025_138886 crossref_primary_10_1021_acs_jafc_5c04278 crossref_primary_10_2217_nnm_2023_0116 crossref_primary_10_1186_s12951_024_02420_9 crossref_primary_10_3390_pharmaceutics15031008 crossref_primary_10_1002_anie_202216188 crossref_primary_10_3390_pharmaceutics17081034 crossref_primary_10_1016_j_molliq_2024_124299 crossref_primary_10_1002_advs_202402473 crossref_primary_10_3390_pharmaceutics15051432 crossref_primary_10_3390_inorganics12060152 crossref_primary_10_15212_bioi_2025_0016 crossref_primary_10_3390_inorganics12060155 crossref_primary_10_1016_j_xphs_2025_103792 crossref_primary_10_1016_j_biomaterials_2025_123705 crossref_primary_10_3390_pharmaceutics17020206 crossref_primary_10_3390_nano15030158 crossref_primary_10_1007_s12633_025_03307_6 crossref_primary_10_3390_nano15171308 crossref_primary_10_1016_j_matlet_2024_136328 crossref_primary_10_1016_j_dental_2025_05_010 crossref_primary_10_3390_pharmaceutics14122636 crossref_primary_10_1007_s11051_025_06383_2 crossref_primary_10_1016_j_jnoncrysol_2024_122938 crossref_primary_10_1038_s41392_024_01889_y crossref_primary_10_1002_advs_202307858 crossref_primary_10_1016_j_colsurfa_2024_134168 crossref_primary_10_1016_j_jconrel_2024_01_005 crossref_primary_10_3390_cosmetics12040134 crossref_primary_10_1016_j_cis_2023_102880 crossref_primary_10_1016_j_bioorg_2025_108710 crossref_primary_10_1016_j_micromeso_2024_113008 crossref_primary_10_1007_s10853_023_08457_9 crossref_primary_10_1016_j_jddst_2025_106740 crossref_primary_10_3390_ijms26125850 crossref_primary_10_3390_pharmaceutics16050632 crossref_primary_10_1016_j_ijbiomac_2024_137193 crossref_primary_10_1007_s13346_024_01609_7 crossref_primary_10_1002_advs_202404431 crossref_primary_10_3390_ijms26178291 crossref_primary_10_1002_adtp_202400239 crossref_primary_10_1007_s13346_025_01950_5 crossref_primary_10_3390_pharmaceutics16010088 crossref_primary_10_3390_pharmaceutics14112382 crossref_primary_10_1021_acs_jafc_5c03048 crossref_primary_10_1002_adhm_202502201 crossref_primary_10_1039_D5RA00948K crossref_primary_10_1016_j_jddst_2024_106015 crossref_primary_10_1002_anie_202216097 crossref_primary_10_1016_j_jddst_2025_107068 crossref_primary_10_1016_j_jconrel_2023_03_027 crossref_primary_10_1016_j_jddst_2025_107066 crossref_primary_10_1002_smll_202401631 crossref_primary_10_1016_j_jcis_2025_138790 crossref_primary_10_1038_s41598_024_65999_x crossref_primary_10_1016_j_bioadv_2024_214081 crossref_primary_10_1002_EXP_20220086 crossref_primary_10_1016_j_seppur_2024_128065 crossref_primary_10_1016_j_ijpharm_2024_124023 crossref_primary_10_1039_D3RA01663C crossref_primary_10_1039_D4NR05298F crossref_primary_10_1515_revic_2024_0003 crossref_primary_10_1016_j_matlet_2024_137860 crossref_primary_10_2217_nnm_2022_0250 crossref_primary_10_1002_smll_202409112 crossref_primary_10_1007_s10971_023_06130_w crossref_primary_10_1039_D5TB00246J crossref_primary_10_1007_s10967_025_09978_0 crossref_primary_10_1016_j_inoche_2023_110469 crossref_primary_10_1016_j_mineng_2024_108874 crossref_primary_10_1142_S179398442540001X crossref_primary_10_1016_j_bcp_2024_116177 crossref_primary_10_1016_j_nantod_2023_101994 crossref_primary_10_1016_j_biotechadv_2023_108277 crossref_primary_10_1007_s44174_025_00280_x crossref_primary_10_1177_08853282241274517 crossref_primary_10_1002_smtd_202401455 crossref_primary_10_1007_s12668_025_01830_9 crossref_primary_10_1039_D5NJ00654F crossref_primary_10_1002_inf2_12559 crossref_primary_10_3390_pharmaceutics15051401 crossref_primary_10_26599_NR_2025_94907080 crossref_primary_10_1016_j_neulet_2025_138286 crossref_primary_10_3390_ijms26136524 crossref_primary_10_3390_pharmaceutics14122670 crossref_primary_10_1002_smll_202407649 crossref_primary_10_1016_j_seppur_2024_126540 crossref_primary_10_1002_ange_202403756 crossref_primary_10_1016_j_inoche_2024_112954 crossref_primary_10_1039_D2BM02102A crossref_primary_10_1016_j_mtbio_2025_102223 crossref_primary_10_1002_cnma_202500095 crossref_primary_10_1080_17425247_2023_2206646 crossref_primary_10_1016_j_molliq_2025_126999 crossref_primary_10_1039_D2NR06224K crossref_primary_10_1002_ange_202216097 crossref_primary_10_1016_j_jcis_2024_04_130 crossref_primary_10_1016_j_cej_2024_155001 crossref_primary_10_1016_j_ejpb_2025_114776 crossref_primary_10_1002_smsc_202400084 crossref_primary_10_1016_j_jcis_2024_01_197 crossref_primary_10_1002_anie_202403756 crossref_primary_10_1021_acs_biomac_5c00316 crossref_primary_10_3390_pharmaceutics14091760 crossref_primary_10_1016_j_addr_2022_114670 crossref_primary_10_1016_j_bbrc_2025_152509 |
| ContentType | Journal Article |
| DBID | CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1039/d1cs00659b |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Chemistry |
| EISSN | 1460-4744 |
| ExternalDocumentID | 35642539 |
| Genre | Journal Article Review |
| GroupedDBID | --- -DZ -~X 0-7 0R~ 29B 4.4 53G 5GY 6J9 705 70~ 7~J 85S AAEMU AAHBH AAIWI AAJAE AAMEH AANOJ AAWGC AAXHV AAXPP ABASK ABDVN ABEMK ABJNI ABPDG ABRYZ ABXOH ACGFO ACGFS ACIWK ACLDK ACNCT ADMRA ADSRN AEFDR AENEX AENGV AESAV AETIL AFLYV AFOGI AFRDS AFRZK AFVBQ AGEGJ AGKEF AGRSR AHGCF ALMA_UNASSIGNED_HOLDINGS ALUYA ANUXI APEMP ASKNT AUDPV AZFZN BLAPV BSQNT C6K CGR COF CS3 CUY CVF DU5 EBS ECGLT ECM EE0 EF- EIF F5P GGIMP GNO H13 HZ~ H~N IDZ J3I M4U N9A NPM O9- P2P R7B R7D RAOCF RCNCU RNS RPMJG RRA RRC RSCEA SKA SKH SLH TN5 TWZ UPT VH6 WH7 ~02 2WC 7X8 AKMSF R56 |
| ID | FETCH-LOGICAL-c527t-efa9d1b2fa2b21df4c5ed058e49df4df8f46a69fd669cb57749a6c12d04ae5f32 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 330 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000803925400001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1460-4744 |
| IngestDate | Fri Jul 11 10:47:34 EDT 2025 Thu Apr 03 06:57:40 EDT 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 13 |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c527t-efa9d1b2fa2b21df4c5ed058e49df4df8f46a69fd669cb57749a6c12d04ae5f32 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 |
| ORCID | 0000-0002-6104-4889 0000-0001-5902-9201 0000-0001-6238-6111 0000-0003-1961-4160 |
| OpenAccessLink | https://pubmed.ncbi.nlm.nih.gov/PMC9252171 |
| PMID | 35642539 |
| PQID | 2672320808 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_2672320808 pubmed_primary_35642539 |
| PublicationCentury | 2000 |
| PublicationDate | 2022-07-04 |
| PublicationDateYYYYMMDD | 2022-07-04 |
| PublicationDate_xml | – month: 07 year: 2022 text: 2022-07-04 day: 04 |
| PublicationDecade | 2020 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England |
| PublicationTitle | Chemical Society reviews |
| PublicationTitleAlternate | Chem Soc Rev |
| PublicationYear | 2022 |
| SSID | ssj0011762 |
| Score | 2.7252934 |
| SecondaryResourceType | review_article |
| Snippet | The present review details a chronological description of the events that took place during the development of mesoporous materials, their different synthetic... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 5365 |
| SubjectTerms | Drug Carriers Drug Delivery Systems - methods Nanoparticles - therapeutic use Porosity Silicon Dioxide Tissue Distribution |
| Title | Engineering mesoporous silica nanoparticles for drug delivery: where are we after two decades? |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/35642539 https://www.proquest.com/docview/2672320808 |
| Volume | 51 |
| WOSCitedRecordID | wos000803925400001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LS8NAEF7UCnrx_agvVvAamux7vRQpFi-WHhR6smyyuyJoUptq8d87mybUiyB4yIaFBLKTyew3j8yH0JXUTlkR04iH_D8Lg-GSRlZxYRTjYABNRTYhBwM1GulhHXAr67LKxiZWhtoWWYiRd4iQsPkDvlHdyXsUWKNCdrWm0FhFLQpQJmi1HC2zCImsCEXBGMQRk4w17Ump7tgkq6jAdfo7tKy2mP72fx9uB23V4BLfLLRhF624fA9t9BpOt3309KP9IH5zZQHoG1x_XL6E2B3OTQ4-dF0qhwHOYjv9eMbWvYbqja9rPIc37LCBYw6nQC-OZ_MCLghV9mX3AD32bx96d1HNsBBlnMhZ5LzRNkmJNyQlifUs487GXDmmYWK98kwYob0VQmcpB6iojcgSYmNmHPeUHKK1vMjdMcKJd8G_NMQFl9PGqRBKp84K6bmhkrfRZSO6MSw6pCVM7mCJ46Xw2uhoIf_xZNFqY0w5-Eec6pM_3H2KNkn4NyHEXtkZann4ft05Ws8-Zy_l9KJSDRgHw_tv-qLE7g |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Engineering+mesoporous+silica+nanoparticles+for+drug+delivery%3A+where+are+we+after+two+decades%3F&rft.jtitle=Chemical+Society+reviews&rft.au=Vallet-Reg%C3%AD%2C+Mar%C3%ADa&rft.au=Sch%C3%BCth%2C+Ferdi&rft.au=Lozano%2C+Daniel&rft.au=Colilla%2C+Montserrat&rft.date=2022-07-04&rft.eissn=1460-4744&rft.volume=51&rft.issue=13&rft.spage=5365&rft_id=info:doi/10.1039%2Fd1cs00659b&rft_id=info%3Apmid%2F35642539&rft_id=info%3Apmid%2F35642539&rft.externalDocID=35642539 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1460-4744&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1460-4744&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1460-4744&client=summon |